Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biocryst Pharma Inc (NQ: BCRX )

14.25 -0.38 (-2.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 17, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,152,173
Open 14.59
Bid (Size) 14.23 (99)
Ask (Size) 14.30 (5)
Prev. Close 14.63
Today's Range 14.25 - 14.68
52wk Range 7.610 - 19.99
Shares Outstanding 185,583,896
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Novavax, Upstart Holdings And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Novavax, Inc. (NASDAQ: NVAX) fell 30.7% to $39.70 in pre-market trading after the company reported second-quarter revenue decline of 37.6% year-over-year to $185.9 million. The company also lowered its... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
  
Via Benzinga

Performance

YTD
+1.28%
+1.28%
1 Month
+25.44%
+25.44%
3 Month
+67.25%
+67.25%
6 Month
-27.88%
-27.88%
1 Year
-0.90%
-0.90%

More News

Read More
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
Via Benzinga
FDA Lifts Clinical Hold On BioCryst's BCX9930 Program For Rare Blood Disorder
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
BioCryst's Voluntary Pause Of Rare Blood Disorder Trial Turns Into FDA Clinical Hold
Via Benzinga
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Via Benzinga
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
Via Benzinga
BioCryst Pharmaceuticals: Q2 Earnings Insights
Via Benzinga
Alibaba, MercadoLibre And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Stocks Rally as Major Indexes Look to End Losing Streaks
Via Talk Markets
BioCryst Gets FDA Fast Track Designation For Bone Formation Disorder Candidate
Via Benzinga
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data
Via Benzinga
7 Cheap Biotech Stocks to Buy Now
Via InvestorPlace
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
Via Benzinga
Recap: BioCryst Pharmaceuticals Q1 Earnings
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
Via Benzinga
7 Top-Rated Biotech Stocks to Buy for Q2
Via InvestorPlace
What 4 Analyst Ratings Have To Say About BioCryst Pharmaceuticals
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022
Via Benzinga
28 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.